This public procurement record has 2 releases in its history.

Award

17 Jul 2026 at 16:50

Planning

19 Jun 2026 at 14:51

Summary of the contracting process

Betsi Cadwaladr University Health Board commissioned outsourced pathology testing services for HFE genes, including sample extraction. The requirement covers laboratory testing and associated blood analysis services. The work supports the Health Board’s healthcare provision and is connected with its operations in Wales. The buying organisation is Betsi Cadwaladr University Health Board, headquartered at Ysbyty Gwynedd in Bangor. The service is a specialist clinical laboratory requirement rather than general medical consultancy or routine administrative support. Suppliers would need to provide the end-to-end testing service, including receiving or handling samples, extracting material and carrying out pathology analysis for HFE gene testing. The requirement was structured as a single contract under one lot, with the intention of appointing one provider.

The procurement has reached award stage: Randox Laboratories Ltd was selected, and the contract is active. The award was made on 17 July 2026, and the contract was signed on the same date. The contract value is £47,000; the tender’s estimated value was £65,000. The process used the Most Suitable Provider Process under the Health Services (Provider Selection Regime) (Wales) Regulations 2025, described as an open procedure. The requirement was evaluated on price. It was a single-contract process, with two bids received, including no bids from SMEs. The tender record shows the lot as cancelled, but the published award and contract records identify an active award to Randox Laboratories Ltd and an active signed contract.

This procurement demonstrates a defined requirement for outsourced genetic pathology testing, including sample extraction and blood analysis, within a Welsh health-board setting. Competitors would need credible clinical laboratory capability covering the complete HFE gene testing workflow, from sample handling and extraction through to accurate pathology results. Relevant suppliers are likely to be established diagnostic laboratories or specialist molecular testing providers able to operate reliably for a public healthcare customer. The award attracted two bids, both from EU-based suppliers, while none came from SMEs, indicating competition from larger or internationally oriented providers. A credible future competitor would therefore need demonstrable technical expertise in genetic testing, dependable laboratory capacity, quality-controlled processes, suitable reporting arrangements and experience delivering specialist diagnostic services to healthcare organisations.

How relevant is this notice?

Notice Title

Pathology Testing Services for HFE Genes

Notice Description

Betsi Cadwaladr University Health Board intends to award a contract to a provider under the Most Suitable Provider Process for the provision of Pathology Testing Services for HFE Genes including extraction

Lot Information

Lot 1

This is a Provider Selection Regime (PSR) Intention to Award Notice. Betsi Cadwaladr University Health Board (BCUHB) intends to to award a contract under the Most Suitable Provider Process under The Health Services (Provider Selection Regime) (Wales) Regulations 2025 for the provision of outsourced pathology testing services for HFE genes, including sample extraction. In accordance with the Most Suitable Provider Process, the Contracting Authority has considered which providers are capable of delivering the service and, having regard to the key criteria and all relevant information available at this time, considers that it has identified the most suitable provider to deliver the requirement. The Contracting Authority intends to award a single contract to the most suitable provider. This Intention to Award Notice will be published for a period of at least 8 days. Additional information: This is a Provider Selection Regime (PSR) Intention to Award a Contract Notice. The contract is subject to The Health Services (Provider Selection Regime) (Wales) Regulations 2025 and is intended to be awarded using the Most Suitable Provider Process.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06b954
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/067988-2026
Current Stage
Award
All Stages
Planning, Award

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85111800 - Pathology services

85111810 - Blood analysis services

Notice Value(s)

Tender Value
£65,000 Under £100K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£47,000 Under £100K

Notice Dates

Publication Date
17 Jul 20261 months ago
Submission Deadline
Not specified
Future Notice Date
10 Jul 2026Expired
Award Date
17 Jul 20261 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
Betsi Cadwaladr University Health Board
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BANGOR
Postcode
LL57 2PW
Postcode Area
Llandudno
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL3 North Wales
Small Region (ITL 3)
TLL32 Gwynedd
Delivery Location
TLL Wales

Local Authority
Gwynedd
Electoral Ward
Y Faenol
Westminster Constituency
Bangor Aberconwy

Supplier Information

Number of Suppliers
1
Supplier Name

Randox Laboratories Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...